Archives of Medical Research

Papers
(The H4-Index of Archives of Medical Research is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection411
Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2278
A Review of Current Interventions for COVID-19 Prevention214
Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals206
Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review180
COVID-19 in Children: Where do we Stand?130
Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease117
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development106
Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More103
Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico97
Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients with COVID-19 in Mexico97
COVID-19: Developing from an Outbreak to A Pandemic75
Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-1975
Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?72
Laboratory Findings of COVID-19 Infection are Conflicting in Different Age Groups and Pregnant Women: A Literature Review68
Molecular Pathology of Primary Non-small Cell Lung Cancer59
COVID-19 Sets off Mass Migration in India58
Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?54
Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review53
Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis53
ChatGPT and Publication Ethics52
Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak49
Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial49
Metformin Increases Exosome Biogenesis and Secretion in U87 MG Human Glioblastoma Cells: A Possible Mechanism of Therapeutic Resistance47
Changes in oxidative markers in COVID-19 patients46
Amantadine Treatment for People with COVID-1945
Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?45
Tumor-derived Exosomes Induced M2 Macrophage Polarization and Promoted the Metastasis of Osteosarcoma Cells Through Tim-344
SARS-CoV-2–A Tough Opponent for the Immune System44
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study44
Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects43
Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial43
Possible Cause of Inflammatory Storm and Septic Shock in Patients Diagnosed with (COVID-19)42
Resolvin D1 Ameliorates Nicotinamide-streptozotocin-induced Type 2 Diabetes Mellitus by its Anti-inflammatory Action and Modulating PI3K/Akt/mTOR Pathway in the Brain41
Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection?41
Messaging Fatigue and Desensitisation to Information During Pandemic41
A Reusable Mask for Coronavirus Disease 2019 (COVID-19)41
COVID-19: Situation of European Countries so Far39
Central Nervous System Involvement in COVID-1939
0.057995796203613